WALVAX BIOTECHNOLOGY CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.07 CNY | -2.21% |
|
+2.45% | -35.90% |
| Apr. 26 | Walvax Biotechnology's Profit Drops 92%, Operating Income Slids 28% in Q1 2024 | MT |
| Apr. 25 | Walvax Biotechnology's Unit to End COVID-19 Vaccine Trial | MT |
Evolution of the average Target Price on Walvax Biotechnology Co., Ltd.
Price target over the last 5 years
History of analyst recommendation changes
9128e6f097e002f9bc.cZ1jG75BefBAw0IK86Yn4p4AkEaI2y5ivY5UuSlqge4.A-0Gdoh5N7sHiQt8tNNRoKpa0RPa628z0OgnjXs40tc0-gdf8iUa3QGMNQ~be2eebac069777fa781000ed949267a3
Analysts' Consensus
Sell
Buy
Mean consensus
HOLD
Number of Analysts
2
Last Close Price
15.07
CNY
Average target price
20
CNY
Spread / Average Target
+32.71%
High Price Target
25
CNY
Spread / Highest target
+65.89%
Low Price Target
15
CNY
Spread / Lowest Target
-0.46%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
C+
EPS Revisions
- Stock Market
- Equities
- 300142 Stock
- Consensus Walvax Biotechnology Co., Ltd.